Is Pharmaids Pharmaceuticals Ltd (524572) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Pharmaids Pharmaceuticals Ltd is a below average quality company .

Is Pharmaids Pharmaceuticals Ltd (524572) undervalued or overvalued?

The key valuation ratios of Pharmaids Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Pharmaids Pharmaceuticals Ltd (524572) share price return in the past 10 years?

Pharmaids Pharmaceuticals Ltd share price has appreciated 19.3% annually (CAGR) over the past ten years.

Is Pharmaids Pharmaceuticals Ltd (524572) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Pharmaids Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Pharmaids Pharmaceuticals Ltd (524572)?

Company share prices are keep on changing according to the market conditions. The current trading price of Pharmaids Pharmaceuticals Ltd (524572) on 17-Apr-2026 16:59:59 at 16:59 is 31.41.

What is the P/E ratio of Pharmaids Pharmaceuticals?

The latest standalone P/E ratio of Pharmaids Pharmaceuticals as of 17-Apr-2026 is 0.00.

What is the P/B ratio of Pharmaids Pharmaceuticals Ltd (524572)?

The latest standalone P/B ratio of Pharmaids Pharmaceuticals Ltd (524572) as of 17-Apr-2026 is 2.03.

What is the 52-week high and low of Pharmaids Pharmaceuticals Ltd (524572)?

The 52-week high of Pharmaids Pharmaceuticals Ltd (524572) is Rs. 73.45 and the 52-week low is Rs. 27.10.

Pharmaids Pharmaceuticals Ltd (524572) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Pharmaids Pharmaceuticals Ltd (524572)
Brand: Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Ltd (524572) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Pharmaids Pharmaceuticals Ltd (524572)

BSE: 524572 NSE:

Key Metrics

Market Cap

₹111 Cr.

P/E Ratio

0.00

Price to Book (P/B)

2.03

Price to Sales (P/S)

13.77

EV/EBITDA

-10.54

Return on Capital Employed (ROCE)

-6.89%

Current Price

₹31.4

Return on Equity (ROE)

-10.80%

Return on Assets (ROA)

-7.48%

Operating Profit Margin

-310%

Net Profit Margin

-310.96%

Gross Profit Margin

-358.3%

Book Value per Share

₹15.5

Sales Growth (YoY)

7700%

Sales Growth (3 Years)

-15.94%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

NAN%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹27 / 73

Net Profit Growth (3 Years)

NAN%

Dividend Yield

0.00%

Promoter Holding

32.99%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Pharmaids Pharmaceuticals Ltd?

Pharmaids Pharmaceuticals Ltd revenue growth is 7,700% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Pharmaids Pharmaceuticals Ltd?

Promoters hold 32.99% of the Pharmaids Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Pharmaids Pharmaceuticals Ltd vs industry peers?

Pharmaids Pharmaceuticals Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Pharmaids Pharmaceuticals Ltd belong to?

Pharmaids Pharmaceuticals Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Pharmaids Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 19% based on the current price.

DeciZen - make an informed investing decision on Pharmaids Pharma

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

3. Price Trend

Pharmaids Pharmaceuticals stock performance

Key Ratios

Is Pharmaids Pharmaceuticals Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-21.2%	7.6%	-29.7%	-3%	-4.5%	1%	1.7%	-64%	-10.9%	-6.9%	-
Value Creation Index ⓘ	-2.5	-0.5	-3.1	-1.2	-1.3	-0.9	-0.9	-5.6	-1.8	-1.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1.7	1.2	0.5	0.6	0	8.6	3.9	0	0	2.3	8
Sales YoY Gr.	-	-28.6%	-62.5%	24.4%	-100%	NA	-53.9%	-100%	NA	7,700%	-
Adj EPS ⓘ	-1.2	-0.8	-1.1	-0.2	0	0.1	0.1	-3.5	-1.4	-2.1	-3.5
YoY Gr.	-	NA	NA	NA	NA	200%	55.6%	-2614.3%	NA	NA	-
BVPS (₹) ⓘ	3.9	4.3	3.1	8.2	8.2	8.3	8.4	10.2	20.2	18.1	15.5
Adj Net Profit ⓘ	-0.4	-0.3	-0.4	-0.2	0	0.1	0.2	-7.6	-5	-7.3	-12
Cash Flow from Ops. ⓘ	0	0.3	-0.2	-0.1	-0.8	0.4	-0.3	-4	-3.4	-7.7	-
Debt/CF from Ops. ⓘ	28.6	0	0	0	0	0	0	0	-3.6	-5.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.8%	NA	-15.9%	7700%
Adj EPS ⓘ	NA	-333%	-345.1%	NA
BVPSⓘ	18.5%	17.1%	28.9%	-10.2%
Share Price	19.3%	16%	11.3%	-51.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-26.2	-18.5	-31.2	-3.8	0.4	1.1	1.7	-48.6	-10.6	-10.8	-20.5
Op. Profit Mgn % ⓘ	-20.5	-28.6	-86	-18.1	0	1.3	3.5	0	-22912.2	-310	-195.8
Net Profit Mgn % ⓘ	-23.6	-21.1	-85.9	-31.6	0	1.1	3.7	0	-17806.3	-311	-151.2
Debt to Equity ⓘ	0.4	0	0	0	0	0	0	0	0.2	0.6	-
Working Cap Days ⓘ	385	470	1,003	2,955	0	334	831	0	71,188	3,120	2,145
Cash Conv. Cycle ⓘ	209	214	359	345	0	3	12	0	14,850	655	-432

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-3.5	-3.9
TTM Sales (₹ Cr.)	8.1	25.5
BVPS (₹) ⓘ	15.5	14
Reserves (₹ Cr.) ⓘ	19	14
P/BV ⓘ	2.03	2.25
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	27.10 / 73.45
All Time Low / High (₹)	1.00 / 87.46
Market Cap (₹ Cr.)	111
Equity (₹ Cr.)	35.3
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Pharmaids Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2	1	0	1	0	9	4	0	0	2
Operating Expenses ⓘ +	2	2	1	1	0	8	4	10	6	10
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	1	1	0	0	0	8	4	1	0	2
Employee Cost	0	0	0	0	0	0	0	1	2	3
Other Costs ⓘ	1	1	0	0	0	0	0	8	4	4
Operating Profit ⓘ	-0	-0	-0	-0	-0	0	0	-10	-6	-7
Operating Profit Margin (%)	-20.5%	-28.6%	-86.0%	-18.1%	-	1.3%	3.5%	-	-22,912.2%	-310.0%
Other Income ⓘ +	0	0	0	0	0	0	0	0	1	1
Exceptional Items ⓘ	0	1	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	2
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0	0	-0	-0	-0	0	0	-10	-6	-9
Tax ⓘ	-0	-0	0	0	-0	-0	-0	-2	-1	-1
Profit After Tax	-0	0	-0	-0	0	0	0	-8	-5	-7
PAT Margin (%)	-23.6%	9.1%	-85.9%	-31.6%	-	1.1%	3.7%	-	-17,805.0%	-311.0%
Adjusted EPS (₹)	-1.2	0.3	-1.2	-0.2	0.0	0.1	0.1	-3.5	-1.4	-2.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1	1	1	8	8	9	9	22	71	64
Share Capital ⓘ	3	3	3	10	10	10	10	21	35	35
Reserves ⓘ	-2	-2	-2	-2	-2	-2	-2	1	36	29
Debt +	0	0	0	0	0	0	0	0	13	39
Long Term Debt	0	0	0	0	0	0	0	0	13	39
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	1	2	2	0	11
Others Liabilities ⓘ	0	0	0	0	-0	-0	-0	-2	-2	-1
Total Liabilities ⓘ	2	2	1	9	8	9	11	22	81	114
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0	0	0	0	17	24
Gross Block	2	0	0	0	1	1	1	0	17	25
Accumulated Depreciation	2	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	2	2	4
Investments ⓘ	0	0	0	0	0	0	0	3	53	53
Inventories	0	0	0	0	0	0	1	0	0	10
Trade Receivables	1	1	1	1	0	0	1	2	0	0
Cash Equivalents	0	1	0	0	0	0	0	13	2	0
Others Assets ⓘ	0	0	1	7	8	7	8	2	7	23
Total Assets ⓘ	2	2	1	9	8	9	11	22	81	114

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0	0	-0	-0	-1	0	-0	-4	-3	-8
PBT ⓘ	-0	0	-0	-0	-0	0	0	-10	-6	-9
Adjustment ⓘ	0	0	-0	0	0	0	0	0	3	2
Changes in Working Capital ⓘ	0	0	0	0	-0	0	-0	6	-0	-1
Tax Paid ⓘ	0	0	-0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-0	0	-0	-0	1	-0	0	-5	-73	-19
Capex	-0	0	-0	-0	-0	-0	0	-2	-16	-9
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-0	-0	0	1	-0	0	-3	-56	-10
Cash Flow From Financing Activity ⓘ +	0	-0	-0	-0	-0	0	0	21	66	25
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	21	54	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-0	0	0	-0	0	0	0	-0	-2
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-0	-0	-0	0	0	0	0	12	27
Net Cash Flow ⓘ	-0	0	-0	-0	-0	0	0	12	-10	-2

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-26.21	7.99	-31.24	-3.76	0.4	1.1	1.69	-49.34	-10.64	-10.8
ROCE (%)	-21.19	7.61	-29.73	-3.02	-4.45	1.04	1.66	-63.95	-10.87	-6.89
Asset Turnover Ratio	0.7	0.56	0.27	0.11	0	1.01	0.4	0	0	0.02
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	237	283	530	457	0	12	75	0	0	24
Inventory Days	63	81	0	0	0	16	58	0	3,011	779
Payable Days	135	242	234	176	0	11	143	861	0	1,049

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Pharmaids Pharmaceuticals Ltd FAQs

The current trading price of Pharmaids Pharma on 17-Apr-2026 16:59 is ₹31.41.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Pharmaids Pharma stood at ₹110.8 Cr

The latest P/E ratio of Pharmaids Pharma as of 16-Apr-2026 is 0.00.

The latest P/B ratio of Pharmaids Pharma as of 16-Apr-2026 is 2.03.

The 52-week high of Pharmaids Pharma is ₹73.45 and the 52-week low is ₹27.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pharmaids Pharma is ₹8.05 ( Cr.) .

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited Incorporated in the year 1989 at Hyderabad (Telangana, India). The company is suppliers of Quality Grade range of Specialty chemicals, Skin care, Hospital care and Generic products in the areas of Orthopedic, Neuro and Gastro etc. Its technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygienic standards. Its professionals strive to offer best quality and high purity to attain maximum client's satisfaction. The company’s offered product range is highly acknowledged in the market for its precise composition long shelf life, hygienic processing techniques, premium quality and high purity.

Business area of the company

The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Products

Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Pharmaids Pharmaceuticals Ltd (524572) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Pharmaids Pharma Share Price